ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
68 hedge funds and large institutions have $27.6M invested in Elevation Oncology in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less capital invested
Capital invested by funds: $140M → $27.6M (-$113M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $31K
Holders
68
Holding in Top 10
–
Calls
–
Puts
$31K
Top Buyers
| 1 | +$2.09M | |
| 2 | +$1.82M | |
| 3 | +$1.07M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.02M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$693K |
Top Sellers
| 1 | -$10.4M | |
| 2 | -$6.71M | |
| 3 | -$6.57M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$4.81M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.54M |